A randomized clinical trial of adjuvant chemotherapy with TS-1 versus UFT following curative operation for Stage III colorectal cancer
Phase 2
- Conditions
- stage III colorectal cancer
- Registration Number
- JPRN-C000000346
- Lead Sponsor
- Boso Clinical Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
:patients with hypersensitivity or allergy to any medicine :Pts. with myelosupression, renal dysfuction, or liver dysfuncion :Pts. with severe postoperative complications :Pt. who is pregnant or is to be pregnant :Pts. with multiple cancers :Pts. who are taking other fluoropyrimidine derivatives :Pts. with severe infection or inflammation :doctor's decision for exclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year disease free survival
- Secondary Outcome Measures
Name Time Method overall survival